APA (7th ed.) Citation

Ferguson, M., Schwarz, T. F., Núñez, S. A., Rodríguez-García, J., Mital, M., Zala, C., . . . Vandermeulen, C. (2024). Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age. Clinical Infectious Diseases, 79(4), 1074. https://doi.org/10.1093/cid/ciae364

Chicago Style (17th ed.) Citation

Ferguson, Murdo, et al. "Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age." Clinical Infectious Diseases 79, no. 4 (2024): 1074. https://doi.org/10.1093/cid/ciae364.

MLA (9th ed.) Citation

Ferguson, Murdo, et al. "Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age." Clinical Infectious Diseases, vol. 79, no. 4, 2024, p. 1074, https://doi.org/10.1093/cid/ciae364.